Jin Medical International Ltd. (ZJYL)
NASDAQ: ZJYL · Real-Time Price · USD
0.1534
+0.0134 (9.57%)
Feb 11, 2026, 12:43 PM EST - Market open

Jin Medical International Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Net Income
1.793.682.882.712.632.21
Depreciation & Amortization
0.380.350.230.360.350.33
Loss (Gain) From Sale of Assets
-00-0.01-0.010
Provision & Write-off of Bad Debts
0.07-0.050.120.03-0.110.08
Other Operating Activities
-0.15-0.260.09-0.09-0-0.08
Change in Accounts Receivable
-0.35-3.91-0.380.333.081.12
Change in Inventory
0.060.081.56-0.50.48-1.39
Change in Accounts Payable
-0.08-0.5-0.65-0.81-0.370.43
Change in Unearned Revenue
-0.21-0.060.02-0.760.65-0.09
Change in Income Taxes
0.010.820.030.16-0.1-0.31
Change in Other Net Operating Assets
-0.21-1.35-0.780.15-0.780.21
Operating Cash Flow
1.3-1.213.111.585.842.5
Operating Cash Flow Growth
215.99%-96.53%-72.95%133.44%-
Capital Expenditures
-2.11-0.14-0.11-0.04-0.04-0.14
Sale of Property, Plant & Equipment
-00.01--0
Sale (Purchase) of Intangibles
0-0.98----
Investment in Securities
-2.7-8.39-7.63-0.45-0.810.29
Other Investing Activities
-4.24--0.36-0.22-2.1
Investing Cash Flow
-9.55-9.51-7.73-0.12-1.07-1.96
Short-Term Debt Issued
-16.95.670.120.773.15
Total Debt Issued
20.6416.95.670.120.773.15
Short-Term Debt Repaid
--5.56-5.89--3.64-3.5
Total Debt Repaid
-10.09-5.56-5.89--3.64-3.5
Net Debt Issued (Repaid)
10.5511.34-0.210.12-2.87-0.34
Issuance of Common Stock
-0.318.34---
Other Financing Activities
---1.21---
Financing Cash Flow
10.5511.656.910.12-2.87-0.34
Foreign Exchange Rate Adjustments
-0.050.27-0.15-0.460.1-0.48
Net Cash Flow
2.261.212.141.122.01-0.28
Free Cash Flow
-0.81-1.352.991.545.82.36
Free Cash Flow Growth
--94.25%-73.44%145.69%-
Free Cash Flow Margin
-3.54%-5.75%15.10%8.03%27.93%14.58%
Free Cash Flow Per Share
-0.01-0.010.020.010.040.01
Cash Interest Paid
0.360.240.01-0.070.14
Cash Income Tax Paid
0.230.210.140.010.30.52
Levered Free Cash Flow
-1.350.69-1.571.344.071.21
Unlevered Free Cash Flow
-1.350.69-1.571.344.081.28
Change in Working Capital
-0.78-4.92-0.2-1.432.96-0.03
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q